Vanta Bioscience Limited Share Price
Vanta Bioscience Limited Returns Calculator
Vanta Bioscience Limited Shareholder Returns
Vanta Bioscience Limited Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
Vanta Bioscience Limited Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1.96 | ₹9.72 | ₹6.28 | ₹9.69 |
| Other Income | ₹0.11 | ₹0.11 | ₹0.69 | ₹0.42 |
| Total Revenue | ₹2.07 | ₹9.83 | ₹6.96 | ₹10.11 |
| Total Expenses | ₹14.70 | ₹18.66 | ₹17.23 | ₹9.88 |
| Profit Before Tax | -₹12.63 | -₹8.83 | -₹10.26 | ₹0.23 |
| Tax | ₹0.66 | -₹0.22 | ₹0.18 | ₹0.09 |
| Profit After Tax | -₹13.29 | -₹8.61 | -₹10.44 | ₹0.13 |
| EPS - Basic | -₹7.56 | -₹3.67 | -₹10.27 | ₹0.14 |
| EPS - Diluted | -₹7.56 | -₹3.67 | -₹10.27 | ₹0.14 |
Cash Flow · Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|
| Profit before tax | -₹8.83 | -₹10.26 | ₹0.23 | ₹0.59 |
| Income before WC changes | ₹1.38 | -₹1.71 | ₹3.89 | ₹3.96 |
| Change in Assets | -₹1.76 | -₹0.21 | ₹1.69 | ₹2.46 |
| Change in Liabilities | ₹3.07 | ₹1.29 | -₹0.30 | ₹0.55 |
| Change in WC | ₹1.31 | ₹1.08 | ₹1.39 | ₹3.01 |
| Cash flow from Operations | ₹2.68 | -₹0.63 | ₹5.28 | ₹6.97 |
| Cash flow from Investing | -₹3.31 | -₹5.91 | -₹17.18 | -₹22.19 |
| Cash flow from Financing | ₹0.69 | ₹6.41 | ₹9.53 | ₹17.78 |
| Total Cash Flow | ₹0.06 | -₹0.13 | -₹2.43 | ₹2.46 |
| Cash (Start of the year) | ₹0.10 | ₹0.22 | ₹2.65 | ₹0.20 |
| Cash (End of the year) | ₹0.16 | ₹0.10 | ₹0.22 | ₹2.65 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹70.52 | ₹68.24 | ₹69.47 | ₹66.91 |
| Current Assets | ₹15.36 | ₹17.16 | ₹15.24 | ₹14.50 |
| Total Assets | ₹85.88 | ₹85.40 | ₹84.71 | ₹81.40 |
| Current Liabilities | ₹26.56 | ₹22.79 | ₹17.75 | ₹17.76 |
| Net Current Asset | -₹11.21 | -₹5.62 | -₹2.50 | -₹3.26 |
| Non-Current Liabilities | ₹55.53 | ₹49.64 | ₹48.03 | ₹34.30 |
| Equity Capital | ₹3.78 | ₹12.97 | ₹18.93 | ₹29.34 |
| Total Equity & Liabilities | ₹85.88 | ₹85.40 | ₹84.71 | ₹81.40 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1.13 | ₹8.56 | ₹5.17 | ₹9.35 |
| Other Income | ₹0.04 | ₹0.05 | ₹0.63 | ₹0.17 |
| Total Revenue | ₹1.17 | ₹8.61 | ₹5.80 | ₹9.52 |
| Total Expenses | ₹3.89 | ₹8.56 | ₹10.00 | ₹9.38 |
| Profit Before Tax | -₹2.72 | ₹0.04 | -₹4.21 | ₹0.14 |
| Tax | -₹0.06 | -₹0.01 | ₹0.03 | ₹0.06 |
| Profit After Tax | -₹2.66 | ₹0.05 | -₹4.24 | ₹0.08 |
| EPS - Basic | -₹4.21 | ₹0.08 | -₹6.71 | ₹0.12 |
| EPS - Diluted | -₹4.21 | ₹0.08 | -₹6.71 | ₹0.12 |
Cash Flow · Standalone
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|
| Profit before tax | ₹0.04 | -₹4.21 | ₹0.14 | ₹0.61 |
| Income before WC changes | ₹3.66 | ₹0.15 | ₹3.57 | ₹3.89 |
| Change in Assets | -₹0.72 | ₹0.03 | ₹2.61 | ₹4.04 |
| Change in Liabilities | ₹1.61 | ₹0.47 | ₹0.52 | ₹3.07 |
| Change in WC | ₹0.89 | ₹0.49 | ₹3.13 | ₹7.11 |
| Cash flow from Operations | ₹4.55 | ₹0.64 | ₹6.70 | ₹11.01 |
| Cash flow from Investing | -₹1.67 | -₹2.53 | -₹8.05 | -₹9.86 |
| Cash flow from Financing | -₹2.81 | ₹1.88 | ₹1.38 | -₹1.07 |
| Total Cash Flow | ₹0.07 | ₹0.00 | ₹0.00 | -₹0.02 |
| Cash (Start of the year) | ₹0.07 | ₹0.07 | ₹0.07 | ₹0.09 |
| Cash (End of the year) | ₹0.14 | ₹0.07 | ₹0.07 | ₹0.07 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹45.44 | ₹40.88 | ₹40.51 | ₹39.40 |
| Current Assets | ₹10.39 | ₹12.03 | ₹11.13 | ₹11.00 |
| Total Assets | ₹55.84 | ₹52.91 | ₹51.64 | ₹50.40 |
| Current Liabilities | ₹18.57 | ₹14.20 | ₹10.25 | ₹9.98 |
| Net Current Asset | -₹8.18 | -₹2.18 | ₹0.89 | ₹1.02 |
| Non-Current Liabilities | ₹20.13 | ₹18.91 | ₹21.65 | ₹16.43 |
| Equity Capital | ₹17.13 | ₹19.79 | ₹19.74 | ₹23.99 |
| Total Equity & Liabilities | ₹55.84 | ₹52.91 | ₹51.64 | ₹50.40 |
About Vanta Bioscience Limited
Vanta Bioscience Limited is an India-based preclinical contract research company. The Company provides services for testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers a host of preclinical safety assessment services for clients from pharmaceuticals, medical devices, nutraceuticals, feed additives, biotech, agrochemicals, cosmetics, and chemical industries. Additionally, it provides risk assessment services to evaluate the safety of active pharmaceutical ingredients, excipients, extractables, leachable, and pharmaceutical impurities resulting from the manufacturing process or product degradation. The Company’s services include discovery toxicology, agro-chemical and chemical safety, biocompatibility studies, diet formulation, and batch release tests. The Company has investments in one of its subsidiaries, Vantaclinical Research Limited.
Vanta Bioscience Limited Financial Highlights
- Revenue: Vanta Bioscience Limited reported revenue of ₹1.98 crore in FY26 vs ₹1.17 crore in FY25. It showed an increase of 69.23% on a yearly basis.
- Operating Profit: Vanta Bioscience Limited reported an operating profit of ₹0.01 crore in FY26 vs ₹2.73 crore in FY25. It showed an increase of 100.37% on a year-on-year basis.
- Net Profit: Vanta Bioscience Limited reported a net profit of ₹0.11 crore in FY26 vs ₹2.67 crore in FY25. It showed an increase of 104.12% on a yearly basis.
Similar Stocks
FAQs on Vanta Bioscience Limited Share Price
What is Vanta Bioscience Limited share price today?
Vanta Bioscience Limited share price is ₹24.09 as on 25 Jun, 2026, 11:26 IST.
How much is the Mutual Fund shareholding in Vanta Bioscience Limited shares?
The Mutual Fund Shareholding in Vanta Bioscience Limited was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Vanta Bioscience Limited shares ?
The 52-week high and low of Vanta Bioscience Limited share is ₹31.33 and ₹14.71 as of 25 Jun, 2026.
What is the market cap of Vanta Bioscience Limited?
The market capitalisation of Vanta Bioscience Limited is ₹13.96 Crores as on 25 Jun, 2026.
What are the stock symbols of Vanta Bioscience Limited?
The stock symbol of Vanta Bioscience Limited is 540729 on the BSE, and the ISIN is INE695X01011.
How to buy Vanta Bioscience Limited shares?
To buy Vanta Bioscience Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
What was yesterday's closing price for Vanta Bioscience Limited shares ?
Vanta Bioscience Limited shares closed yesterday at ₹24.09 on BSE
Can I buy Vanta Bioscience Limited shares on Holidays?
No, shares of Vanta Bioscience Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Vanta Bioscience Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.